DEVELOPMENT OF UR238, THE FIRST SMALL-MOLECULE INHIBITOR OF HE4 FOR TREATMENT OF OVARIAN CANCER

$385,000FY2021Department of the ArmyDOD

University Of Rochester, Rochester NY

Investigators